Early research (Phase 1)Study completedNCT00028899
What this trial is testing
Monoclonal Antibody Plus Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes
Who this might be right for
LeukemiaMyelodysplastic Syndromes
Children's Oncology Group 47